Despite reports this fall that the two payers had reopened merger talks, Cigna plans to use excess cash to buy back its ...

As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of ...

Cigna CEO David Cordani threw cold water ... On Thursday’s call, Cordani skewered recent efforts by the Federal Trade Commission to crack down on PBMs, following through on his pledge earlier ...

The Federal Trade Commission recently increased the pre-merger reporting requirements for healthcare deals and is already embroiled with Cigna as its probes the pharmacy benefit management industry.

Cigna shareholders balked at a massive deal that would likely be dilutive to them. And many wondered if the regulatory risk was worth the attempt, given Federal Trade Commission Chair Lina Khan ...

Several US health insurers saw notable stock price gains following the reelection of former US President Donald Trump amid an ...

The company said third-quarter earnings per share were $4.16 on $29.4 billion in revenue. Analysts anticipated EPS at $3.42 on sales of $28.7 billion, according to the median estimate on FactSet.

Healthcare investors are desperate for big returns in a second Trump term. But his health policy proposals are making them ...

Humana, meanwhile, is looking to revive merger talks with Cigna Group (CI ... amid concern that the Federal Trade Commission would prevent a merger.

President Donald Trump has won back the White House, and with his win, many health plans are seeing their stocks rise. | ...